Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Am J Gastroenterol. 2021 Jul 1;116(7):1406–1413. doi: 10.14309/ajg.0000000000001228

Table 1.

Baseline Demographic and Clinical Characteristics Overall and Stratified by Medication Treatment of Opioid Use Disorder (MOUD)

Characteristics Total Cohort Cohort by MOUD Status

N=5600 No MOUD (n=4878) MOUD (n=722) p-value

Demographics

Age (mean, sd) 56.8 (6.6) 56.6 (6.6) 57.8 (6.9) <0.0001

BMI (mean, sd)* 28.4 (5.8) 28.4 (5.8) 28.2 (6.0) 0.237

Race/Ethnicity (N, %) <0.0001
 Non-Hispanic White 3380 (62.1) 3008 (63.5) 372 (6.9)
 Non-Hispanic Black 1226 (22.5)) 1008 (21.3) 218 (31.1)
 Hispanic 582 (10.7) 501 (10.6) 81 (11.5)
 Other Race/ethnicity 255 (4.7) 224 (4.7) 31 (4.4)

Female (N, %) 138 (2.5) 130 (2.7) 8 (1.1) 0.012

Marital status (N, %) 0.023
 Married 1239 (24.5) 1093 (24.8) 146 (22.7)
 Single 1060 (21.0) 899 (20.4) 161 (25.0)
 Divorced/widowed 2761 (54.6) 2425 (54.9) 336 (52.3)

Homeless (N, %) 800 (14.3) 706 (14.5) 94 (13.0) 0.297


Liver Disease Factors

Etiology (N, %) <0.001
 Hepatitis C 4619 (82.5) 3954 (81.1) 665 (92.1)
 Alcohol 871 (15.6) 822 (16.9) 49 (6.8)
 Other/unspecified 110 (1.9) 102 (2.1) 8 (1.1)

Prior decompensation (N, %) 411 (7.3) 363 (7.4) 48 (6.7) 0.445

Hepatocellular carcinoma (N, %) 92 (1.6) 75 (1.5) 17 (2.4) 0.107

Prior hepatitis C treatment 122 (2.2) 110 (2.3) 12 (1.7) 0.308

MELD* (mean, sd) 9.6 (4.0) 9.6 (4.0) 9.8 (4.0) 0.321


Substance Use Disorders

Nicotine use disorder (N, %) 1719 (30.7) 1476 (30.3) 243 (33.7) 0.065

Alcohol use disorder (N, %) 1779 (31.8) 1589 (32.6) 190 (26.3) <0.001

Other substance use disorders (N, %) 1737 (31.0) 1470 (30.1) 267 (37.0) <0.001


Other Comorbidities

Pain related diagnosis (N, %) 2930 (52.3) 2600 (53.3) 330 (45.7) <0.001

Prior prescription opioids (N, %)
  Any opioid 2935 (52.4) 2666 (54.7) 269 (37.3) <0.001
    Hydrocodone 1368 (24.4) 1251 (25.7) 117 (16.2) <0.001
    Oxycodone 1140 (20.4) 1031 (21.1) 109 (15.1)
    Morphine 690 (12.3) 642 (13.2) 48 (6.7)

Mood disorders (N, %) 2238 (40.0) 1964 (40.3) 274 (38.0) 0.236

Anxiety disorders (N, %) 622 (11.1) 549 (11.3) 73 (10.1) 0.361

Schizophrenia (N, %) 318 (5.7) 283 (5.8) 35 (4.9) 0.301

Post-traumatic stress disorder (N, %) 1055 (18.8) 941 (19.3) 114 (15.8) 0.025

Charlson comorbidity index (mean, sd) 0.82 (1.05) 0.82 (1.05) 0.82 (1.05) 0.961
*

BMI=body mass index; MELD=model for end-stage liver disease; sd=standard deviation; missing data: MELD N=3,007, marital status for N=540, and for race N=157; for characteristics with missing data, %s are calculated based on the non-missing total number